RNS Number:7454G
Reed Health Group PLC
29 January 2003
                                                                 29 January 2003

                             Reed Health Group plc

                        ("Reed Health" or "the Company")

               Board Appointments and Notice of Interim Results


The Board of Reed Health is pleased to announce that David Fennell, currently
acting Chief Executive, has been formally appointed as Chief Executive and to
the Board.  In addition, the Company is also pleased to announce the appointment
of Mark Garratt as Group Finance Director.  Both appointments are with effect
from 28 January 2003.

David Fennell was appointed acting Chief Executive of Reed Health in November
2002.  Previously he was Chief Executive of The Locum Group Limited, which was
acquired by Reed Health in May 2002.  Mr Fennell, aged 52, has spent his career
within specialist personnel recruitment and for the last decade has been
specifically involved in the health care sector.  He joined The Locum Group as
Chief Executive in November 1997, a position he held until its takeover by Reed
Health Group.  During that period turnover increased, organically, from #14
million to #48 million per annum.

Mark Garratt, aged 37, joins Reed Health from Cater Barnard plc, a company
listed on AIM, where he was Group Finance Director.  Mr Garratt has spent his
commercial career in financial management in Business to Business service
organisations including, for the past eight years, as a Finance Director.
Previously, he has been Finance Director of AIM listed Envesta plc, Glendinning
Management Consultants, which is now part of WPP, and Interior plc, now part of
Interior Services Group plc.  Mr Garratt qualified as a chartered accountant
with Grant Thornton. A full list of Mark Garratt's previous directorships is set
out in the appendix.

Lord Tom Sawyer, Chairman of Reed Health, commented:

"We are delighted to have formally appointed David to the Board of Reed Health
and that Mark is joining the Company.  Both David and Mark's relevant
experiences will be invaluable to the Company as it moves into the next phase of
development".

Reed Health's interim results for the six months ending 31 December 2002 will be
announced on 25 February 2003.

                                    - Ends -


For further information, please contact:


Reed Health Group plc                                        020 7834 3181
Lord Tom Sawyer, Chairman

Weber Shandwick Square Mile                                  020 7067 0700
Louise Robson or Graham Herring


Notes to Editors:

A list of Mark Garratt's previous directorships can be found below:

Advanced Minerals International plc
C3 Holdings
Cater Barnard plc
Cater Barnard Securities Ltd
Cater Barnard (UK) Ltd
Cater Barnard (USA) plc
Envesta plc
Garratt Consultancy Ltd
Glendinning Management Consultants
Harvest Gold plc
IMX Pharmaceuticals Inc
Logical Investments Ltd
Lonminfin plc
London Mining Investments Ltd
LMF Securities plc
Orevest plc
Parkgreen Communications Ltd
St. James' Securities Ltd
St. James Technology Investments plc
Thurloe Corporate Finance (UK) Ltd
Thurloe Internet Services Ltd

No further details should be disclosed under rule 16.4(a) or (b) of the UK
Listing Rules.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCBIGDBSGDGGXI

Reed Health (LSE:RHG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Reed Health Charts.
Reed Health (LSE:RHG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Reed Health Charts.